Bioprinting Market Forecast To Reach $6.68 Billion By 2030: Key Trends Explained
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Bioprinting Market Growth From $3.27 Billion In 2026 To $6.68 Billion By 2030 At A CAGR Of 19.5%
The bioprinting market size has experienced rapid expansion in recent years. It is anticipated to increase from $2.73 billion in 2025 to $3.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.8%. This historical growth can be attributed to the rising demand for tissue reconstruction, a growing need for organ transplants, an increasing burden of chronic diseases, a shortage of donor organs, and a rising aging population.
The bioprinting market is projected to experience substantial expansion over the coming years. Its value is anticipated to reach $6.68 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.5%. This forecasted growth stems from factors such as the increasing demand for regenerative medicine, expanding applications in drug testing and development, growing investments in research and development, a rising prevalence of chronic diseases, and an increasing interest in personalized medicine. Prominent trends throughout the forecast period include technological advancements in bioprinting hardware, innovations in bioinks and biomaterials, the development of customized 3D tissue and organ models, increased utilization in pharmaceutical drug development and testing, and a rise in public-private research collaborations within biofabrication.
Get A Free Sample Report With In-Depth Market Insights:
Bioprinting Market Demand Drivers Opening New Revenue Streams
The increasing need for individualized healthcare approaches is anticipated to drive the expansion of the bioprinting market in the future. Personalized medicine represents a healthcare strategy focused on customizing treatments for patients, taking into account their unique genetic makeup, environmental influences, and lifestyle choices to enhance results and patient care. This growing demand for personalized medicine is fueled by progress in genomic technologies, which facilitate accurate identification of genetic differences and the development of specific treatments for individuals. Bioprinting contributes to personalized medicine by allowing the production of tissues and organ models that are specific to a patient, aligning with their distinct biological characteristics. This technology boosts the accuracy of treatments through its support for bespoke drug trials, regenerative medicine applications, and more effective forecasting of how patients will respond. As an illustration, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit, indicated that the U.S. Food and Drug Administration (FDA) sanctioned 26 novel personalized medications in 2023, which marked a considerable rise from the 12 approved in 2022. Consequently, the expanding requirement for personalized medicine is propelling the development of the bioprinting market.
Bioprinting Market Segment Performance And Emerging Opportunities
The bioprinting market covered in this report is segmented –
1) By Product: 3D Bioprinters, Bioinks, 3D Bioprinted Products And Services
2) By Material: Living Cells, Hydrogels, Extracellular Matrices, Biomaterials, Other Materials
3) By Technology: Inkjet Bioprinting, Extrusion Bioprinting, Laser-Assisted Bioprinting, Magnetic Levitation Bioprinting, Other Technologies
4) By Application: Tissue Engineering, Regenerative Medicine, Drug Development, Research, Other Applications
5) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End-Users
Subsegments:
1) By 3D Bioprinters: Inkjet Bioprinters, Extrusion Bioprinters, Laser Assisted Bioprinters, Magnetic Levitation Bioprinters, Microvalve Bioprinters
2) By Bioinks: Natural Polymer Bioinks, Synthetic Polymer Bioinks, Composite Bioinks, Cell Laden Bioinks, Extracellular Matrix Based Bioinks
3) By 3D Bioprinted Products And Services: Bioprinted Tissue Models, Bioprinted Organ Models, Custom Bioprinting Services, Disease Modeling Products, Regenerative Medicine Constructs
Bioprinting Market Trends Powering Strategic Industry Growth
Companies operating in the bioprinting market are increasingly focused on developing advanced resin materials, such as polyester-based volumetric bioprinting resins. These innovations aim to facilitate the rapid fabrication of complex tissue constructs, ensuring high resolution and biocompatibility. Polyester-based volumetric bioprinting resins are specifically engineered to create entire three-dimensional structures instantly, rather than through a layer-by-layer process, thereby supporting intricate tissue models crucial for regenerative medicine and tissue engineering research. For example, in May 2025, BIO INX, a Belgium-based bioink technology company, collaborated with Readily3D, a Switzerland-based bioprinter developer, to introduce READYPCL INX. This polyester-based resin supports high-speed volumetric printing, achieving resolutions as fine as 100 µm. It also provides robust mechanical performance, full biodegradability, and ISO 10993-5 biocompatibility, making it highly suitable for complex bone and cartilage applications. This introduction signifies a major advancement in bioprinting technology, effectively combining speed, precision, and biocompatibility to further next-generation tissue engineering and regenerative medicine research.
Bioprinting Market Leading Companies And Competitive Benchmarking
Major companies operating in the bioprinting market are GeSiM GmbH, Poietis SAS, Stratasys Ltd., BICO Group AB, Cyfuse Biomedical K.K., Inventia Life Science Pty Ltd., Aspect Biosystems Ltd., CollPlant Biotechnologies Ltd., Pandorum Technologies Pvt. Ltd., ROKIT Healthcare Inc., Prellis Biologics Inc., 3D Systems Corporation, RegenHU Ltd., REGEMAT 3D S.L., 3DBio Therapeutics Inc., Brinter Ltd., Allevi Inc., Next Big Innovation Labs, Precise Bio Inc., TissueLabs Inc., Fluicell AB, XLife Sciences, Organovo Holdings Inc.
View The Full Bioprinting Market Report:
Bioprinting Market Top Region By Revenue And Market Share
North America was the largest region in the bioprinting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprinting market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model